Cardiac Metabolism and Signaling in Heart Failure Pathogenesis and Treatment

心力衰竭发病机制和治疗中的心脏代谢和信号转导

• 批准号: 388681
• 负责人: Dyck Jason R
• 金额: $ 229.39万
• 依托单位: University of Alberta
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2018
• 资助国家: 加拿大
• 起止时间: 2018-09-01 至 2025-09-01
• 项目状态: 未结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=388681&lang=en
• 关键词: Cardiovascular Disease; Molecular Biology

Although advancements in therapies to treat cardiovascular disease have reduced the number of deaths of patients with heart disease, these treatments/interventions have ultimately increased the number of people who eventually go on to develop another clin

尽管心血管疾病治疗方法的进步减少了心脏病患者的死亡人数，但这些治疗/干预措施最终增加了最终发展为另一种临床症状的人数。